These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15197950)

  • 21. Increased risk of malignancy and blood-membrane interactions in uraemic patients.
    Akizawa T; Kinugasa E; Koshikawa S
    Nephrol Dial Transplant; 1994; 9 Suppl 2():162-4. PubMed ID: 8065609
    [No Abstract]   [Full Text] [Related]  

  • 22. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid function in uremic children.
    De Santo NG; Fine RN; Carella C; Leumann E; Amato G; Fine S; Nuzzi F; Capasso G; Capodicasa G; Lama G
    Kidney Int Suppl; 1985 Dec; 17():S166-9. PubMed ID: 3867789
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative losses of free amino acids and their plasma variations in artificial substitutive programmes for chronic uraemia.
    Scolari MP; Stefoni S; Mosconi G; Feliciangeli G; Colì L; Bonomini V
    Life Support Syst; 1983; 1(1):51-60. PubMed ID: 6678371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can hemodialysis remove the factor that suppresses platelet cyclo-oxygenase activity in uremic patients?
    Tanaka H; Umimoto K; Izumi N; Maekawa T; Kishimoto T; Maekawa M
    Trans Am Soc Artif Intern Organs; 1985; 31():552-5. PubMed ID: 3939277
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of uremic patients by automated peritoneal dialysis: study of 78 cases].
    Karoui C; Ben Hamida F; Cherif M; Barbouch S; Kaaroud H; Ounissi M; Abderrahim E; Ben Abdallah T; Ben Moussa F; Ben Maiz H; Kheder A
    Tunis Med; 2007 Mar; 85(3):225-9. PubMed ID: 17668579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why are dialysis patients malnourished?
    Bergström J
    Am J Kidney Dis; 1995 Jul; 26(1):229-41. PubMed ID: 7611257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of the diabetic with terminal renal failure].
    Ritz E; Bommer J; Andrassy K
    MMW Munch Med Wochenschr; 1983 Jun; 125(24):516-20. PubMed ID: 6410221
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of chronic renal failure in children].
    Hattori M; Ito K
    Nihon Rinsho; 1992 Jan; 50 Suppl():88-95. PubMed ID: 1578783
    [No Abstract]   [Full Text] [Related]  

  • 30. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nutritional management in chronic hemodialysis].
    Ishigai T; Kto K; Maeda Y; Owada A
    Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1648-52. PubMed ID: 8537718
    [No Abstract]   [Full Text] [Related]  

  • 32. Continuous ambulatory peritoneal dialysis.
    Maher JF; Maher AT
    Am Fam Physician; 1989 Nov; 40(5):187-92. PubMed ID: 2683690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of larger molecules on cellular response in uremia.
    Giacchino F; Quarello F; Pozzato M; Giraudo G; Formica M; Quattrocchio G; Piccoli G
    Trans Am Soc Artif Intern Organs; 1983; 29():29-32. PubMed ID: 6608816
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations].
    Garini G; Savazzi G; Arisi L
    Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795
    [No Abstract]   [Full Text] [Related]  

  • 36. Malnutrition in continuous ambulatory peritoneal dialysis and use of intraperitoneal amino acids.
    Dombros NV; Digenis GE; Oreopoulos DG
    Contrib Nephrol; 1992; 100():188-206. PubMed ID: 1458902
    [No Abstract]   [Full Text] [Related]  

  • 37. [Massive, unilateral and recurrent hydrothorax in a patient in a chronic intermittent peritoneal dialysis program].
    Haag B
    Z Urol Nephrol; 1987 Apr; 80(4):239-41. PubMed ID: 3630426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dietetic problems connected with amino acid depletion in renal insufficiency under dialysis therapy].
    Bucciante G; Costa A; Bernardi A; De Toni R; Costa C
    G Clin Med; 1980 May; 61(5):321-31. PubMed ID: 7450353
    [No Abstract]   [Full Text] [Related]  

  • 39. Experience with aluminum-associated bone disease in end-stage renal disease patients.
    Joglar FM; Rivera CG; Burgos R; Huffer WE
    Transplant Proc; 1991 Apr; 23(2):1823-4. PubMed ID: 2053166
    [No Abstract]   [Full Text] [Related]  

  • 40. Propafenone pharmacokinetics in uremic patients treated by peritoneal dialysis.
    Poirier JM; Joannides R; Geffroy-Josse S; Fillastre JP; Etienne I
    Clin Nephrol; 1992 Oct; 38(4):231-2. PubMed ID: 1424311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.